(Q43412825)

23 November 2017

title

Safety and tolerability of a high-potency zoster vaccine in adults >/= 50 or years of age. (English)

1 reference

23 November 2017

5

Gregory Poland

1 reference

23 November 2017

6

William M Cassidy

1 reference

23 November 2017

Stephen K Tyring

1

1 reference

23 November 2017

Francisco Diaz-Mitoma

2

1 reference

23 November 2017

Larry G Padget

3

1 reference

23 November 2017

Margarita Nunez

4

1 reference

23 November 2017

Nickoya D Bundick

7

1 reference

23 November 2017

Jianjun Li

8

1 reference

23 November 2017

Ivan S F Chan

9

1 reference

23 November 2017

Jon E Stek

10

1 reference

23 November 2017

Paula W Annunziato

11

1 reference

23 November 2017

Protocol 009 Study Group

12

1 reference

23 November 2017

language of work or name

English

0 references

publication date

30 October 2006

1 reference

23 November 2017

1 reference

23 November 2017

volume

25

1 reference

23 November 2017

issue

10

1 reference

23 November 2017

page(s)

1877-1883

1 reference

Clinical practice. Herpes zoster

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.027

Epidemiology of Varicella-Zoster Virus in England and Wales

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.027

Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.027

Herpes zoster and its complications in Italy: an observational survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.027

The incidence of herpes zoster

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.027

The incidence of herpes zoster in a United States administrative database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.027

Herpes zoster in older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.027

NIH conference. Varicella-zoster virus infections. Biology, natural history, treatment, and prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.027

The natural history of herpes zoster

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.027

Epidemiology of varicella zoster virus infection in Canada and the United Kingdom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.027

The prognosis with postherpetic neuralgia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.027

Postherpetic neuralgia--pathogenesis, treatment, and prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.027

Risk factors for postherpetic neuralgia in patients with herpes zoster

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.027

Are current therapies useful for the prevention of postherpetic neuralgia? A critical analysis of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.027

Famciclovir for the Treatment of Acute Herpes Zoster: Effects on Acute Disease and Postherpetic Neuralgia: A Randomized, Double-Blind, Placebo-Controlled Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.027

Treatment of postherpetic neuralgia: a review of therapeutic options

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.027

Management of herpes zoster (shingles) and postherpetic neuralgia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.027

A retrospective study of the clinical presentation and outcome of herpes zoster in a tertiary dermatology outpatient referral clinic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.027

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.027

10.1016/J.VACCINE.2006.10.027

7 January 2021

Identifiers

DOI

1 reference

23 November 2017

1 reference